Debiopharm (@debiopharmnews) 's Twitter Profile
Debiopharm

@debiopharmnews

We are an independent biopharmaceutical company with an ongoing commitment to improve patient outcomes & quality of life in oncology & bacterial infections

ID: 1617968917

linkhttp://www.debiopharm.com calendar_today24-07-2013 14:55:18

850 Tweet

741 Followers

99 Following

Debiopharm (@debiopharmnews) 's Twitter Profile Photo

#Antimicrobialresistance (AMR) is a critical #globalhealth Debiopharm is committed to combat. At the 2024 World AMR conference, our Head of Global Value & Access will discuss #marketaccess solutions and drive the dialogue on #reimbursement challenges. bit.ly/4gcwUca

Debiopharm (@debiopharmnews) 's Twitter Profile Photo

Are you attending the Swiss #Urology Congress in Lugano next week? Get in touch with our Marketing and Sales team at our booth. Our team will be happy to network as well as provide you with practical USB keys containing slides from all SGU presentations! #cancer #triptorelin

Are you attending the Swiss #Urology Congress in Lugano next week? Get in touch with our Marketing and Sales team at our booth. Our team will be happy to network as well as provide you with practical USB keys containing slides from all SGU presentations! 
#cancer #triptorelin
Debiopharm (@debiopharmnews) 's Twitter Profile Photo

Great news for #children affected by Central Precocious Puberty and their families! The phase III LIBELULA #clinicaltrial has been launched to evaluate Debio 4326, a 12-month extended-release #triptorelin formulation. bit.ly/3MEV29I #patientcentricity #qualityoflife

Debiopharm (@debiopharmnews) 's Twitter Profile Photo

Today, we're celebrating great news for the future of #cancer patients! The worldwide development and commercialization rights for our first-i-class, peptide-based #radioligandtherapy programs have exclusively been licensed to ITM Isotope Technologies Munich SE! 🎉 bit.ly/3zhOcUE #biotech

Debiopharm (@debiopharmnews) 's Twitter Profile Photo

Excited to share that our Head of Global Value & Access, Jennifer Quinn, was featured in Contagion Live! In her interview, Jennifer discusses critical insights for improving patient outcomes and tackling #antibiotic #development challenges. bit.ly/482BgPb

Debiopharm (@debiopharmnews) 's Twitter Profile Photo

Did you know that most bone & joint #infections are caused by staphylococci #bacteria which are known to easily become drug-resistant? Our new video summarizes key points from our phase 2 #clinicaltrial evaluating an ultra-narrow spectrum approach for BJIs youtu.be/jVpOdbL7JDI

Debiopharm (@debiopharmnews) 's Twitter Profile Photo

Today, we share the first of three interviews, in which Anna Barbera, one of the two founders, narrates how, from a dramatic event like #breastcancer, an earth-shattering initiative can be born. Follow Debiopharm and stay tuned for the next two interviews! youtu.be/wRTZ3rT0JxE

Debiopharm (@debiopharmnews) 's Twitter Profile Photo

How could theater and Greek mythology serve as cathartic metaphors for the battle against #breastcancer? The response is here 👇 youtu.be/l4aMvVll6Oo #cancer #BreastCancerAwareness #Oncology #patientsupport

Debiopharm (@debiopharmnews) 's Twitter Profile Photo

At the Centro Amazzone, volunteers like Rosaria have dedicated themselves to providing recurrent #mentalhealth check-ups. She would like to do a quick exercise with you right now. What would be your reply? youtu.be/e79k58dVUok #brestcancerawareness #cancer